Kalpit A. Vora

4.8k total citations · 2 hit papers
62 papers, 3.3k citations indexed

About

Kalpit A. Vora is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Kalpit A. Vora has authored 62 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 23 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Kalpit A. Vora's work include T-cell and B-cell Immunology (16 papers), Respiratory viral infections research (15 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Kalpit A. Vora is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Respiratory viral infections research (15 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Kalpit A. Vora collaborates with scholars based in United States, India and United Kingdom. Kalpit A. Vora's co-authors include Martin Scott, Teresa G. Cachero, Tim Manser, Barbara J. Schiemann, Jennifer L. Gommerman, Max Dobles, Svetlana Shulga‐Morskaya, Mohammad Zafari, Fang Qian and Jeffrey L. Browning and has published in prestigious journals such as Science, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Kalpit A. Vora

62 papers receiving 3.2k citations

Hit Papers

An Essential Role for BAFF in the Normal Development of B... 2001 2026 2009 2017 2001 2001 250 500 750

Peers

Kalpit A. Vora
Bernardetta Nardelli United States
Annaiah Cariappa United States
Jean-Luc Bodmer Switzerland
Zhenming Xu United States
Anke Peters Germany
Kalpit A. Vora
Citations per year, relative to Kalpit A. Vora Kalpit A. Vora (= 1×) peers Toshitada Takemori

Countries citing papers authored by Kalpit A. Vora

Since Specialization
Citations

This map shows the geographic impact of Kalpit A. Vora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalpit A. Vora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalpit A. Vora more than expected).

Fields of papers citing papers by Kalpit A. Vora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalpit A. Vora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalpit A. Vora. The network helps show where Kalpit A. Vora may publish in the future.

Co-authorship network of co-authors of Kalpit A. Vora

This figure shows the co-authorship network connecting the top 25 collaborators of Kalpit A. Vora. A scholar is included among the top collaborators of Kalpit A. Vora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalpit A. Vora. Kalpit A. Vora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fridman, Arthur, Latisha Love‐Gregory, Radha Railkar, et al.. (2025). P-2334. Clesrovimab Binding Site Conservation on the RSV F Protein: An Evaluation of RSV Molecular Sequencing Data from 2019-2023 and GenBank Sequence Analysis. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations
2.
Manolaridis, Ioannis, Christopher L. Warren, Aimin Tang, et al.. (2025). Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus. Vaccines. 13(1). 35–35. 1 indexed citations
3.
Plock, Nele, Jeffrey R. Sachs, Kalpit A. Vora, et al.. (2025). Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease. Communications Medicine. 5(1). 119–119. 5 indexed citations
4.
Deng, James Z., Zhifeng Chen, Yue Yuan, et al.. (2024). Identification and Quantification of a Pneumococcal Cell Wall Polysaccharide by Antibody-Enhanced Chromatography Assay. Vaccines. 12(5). 469–469. 3 indexed citations
5.
Phuah, Jia Yao, Ryan P. Staupe, Yu Cao, et al.. (2024). Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150. The Journal of Infectious Diseases. 231(3). e488–e496. 4 indexed citations
6.
Phuah, Jia Yao, Brian M. Maas, Aimin Tang, et al.. (2023). Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults. Biomedicine & Pharmacotherapy. 169. 115851–115851. 22 indexed citations
7.
Staupe, Ryan P., Alex M. Tamburino, Dan Chang, et al.. (2022). Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells. Communications Biology. 5(1). 1399–1399. 4 indexed citations
8.
Li, Hualin, Daniel C. Freed, Dan Chang, et al.. (2021). Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates. Vaccine. 39(51). 7446–7456. 15 indexed citations
9.
10.
Li, Leike, Weixu Meng, Melanie Horton, et al.. (2019). Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes. PLoS Pathogens. 15(6). e1007716–e1007716. 30 indexed citations
11.
Wen, Zhiyun, Andrew J. Bett, Amy S. Espeseth, et al.. (2018). Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging. Journal of Virological Methods. 263. 88–95. 13 indexed citations
12.
Chen, Zhifeng, Kara S. Cox, Aimin Tang, et al.. (2018). Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response. BMC Infectious Diseases. 18(1). 613–613. 11 indexed citations
13.
Chen, Zhifeng, Lan Zhang, Aimin Tang, et al.. (2016). Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein. PLoS ONE. 11(6). e0156798–e0156798. 22 indexed citations
14.
Natarajan, S., Luping Liu, James E. Thompson, et al.. (2006). p38 MAP kinase inhibitors. Part 5: Discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffold. Bioorganic & Medicinal Chemistry Letters. 16(20). 5468–5471. 11 indexed citations
15.
Vora, Kalpit A., Li‐Chun Wang, Sambasiva P. Rao, et al.. (2003). Cutting Edge: Germinal Centers Formed in the Absence of B Cell-Activating Factor Belonging to the TNF Family Exhibit Impaired Maturation and Function. The Journal of Immunology. 171(2). 547–551. 124 indexed citations
16.
Vora, Kalpit A., Vicky M. Lentz, Sambasiva P. Rao, et al.. (2001). The T Cell-Dependent B Cell Immune Response and Germinal Center Reaction Are Intact in A-myb-Deficient Mice. The Journal of Immunology. 166(5). 3226–3230. 4 indexed citations
17.
Qin, Dahui, Jiuhua Wu, Kalpit A. Vora, et al.. (2000). Fcγ Receptor IIB on Follicular Dendritic Cells Regulates the B Cell Recall Response. The Journal of Immunology. 164(12). 6268–6275. 146 indexed citations
18.
Vora, Kalpit A., et al.. (1998). A Periarteriolar Lymphoid Sheath-Associated B Cell Focus Response Is Not Observed During the Development of the Anti-Arsonate Germinal Center Reaction. The Journal of Immunology. 160(2). 728–733. 29 indexed citations
19.
Manser, Tim, et al.. (1998). The roles of antibody variable region hypermutation and selection in the development of the memory B‐cell compartment. Immunological Reviews. 162(1). 183–196. 34 indexed citations
20.
Shailubhai, Kunwar, Sudhir Sahasrabudhe, Kalpit A. Vora, & V. V. Modi. (1983). Degradation of chlorinated derivatives of phenoxyacetic acid and benzoic acid byAspergillus niger. FEMS Microbiology Letters. 18(3). 279–282. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026